Home/Filings/4/0000899243-21-011890
4//SEC Filing

Barclay Alec 4

Accession 0000899243-21-011890

CIK 0001492674other

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 12:41 PM ET

Size

7.0 KB

Accession

0000899243-21-011890

Insider Transaction Report

Form 4
Period: 2021-03-14
Barclay Alec
SVP, Operations
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2021-03-1421,66743,333 total
    Common Stock (21,667 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-14+21,66786,914 total
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]On March 14, 2020 the reporting person was granted 65,000 RSU's that vest in three equal annual installments beginning on March 14, 2021.

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001734339

Filing Metadata

Form type
4
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 12:41 PM ET
Size
7.0 KB